Incidental Mutation 'IGL02701:Blmh'
ID 304134
Institutional Source Australian Phenomics Network (link to record)
Gene Symbol Blmh
Ensembl Gene ENSMUSG00000020840
Gene Name bleomycin hydrolase
Synonyms
Accession Numbers
Essential gene? Possibly non essential (E-score: 0.323) question?
Stock # IGL02701
Quality Score
Status
Chromosome 11
Chromosomal Location 76836482-76878215 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 76862736 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Aspartic acid to Glycine at position 383 (D383G)
Ref Sequence ENSEMBL: ENSMUSP00000021197 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000021197] [ENSMUST00000168124]
AlphaFold Q8R016
Predicted Effect probably benign
Transcript: ENSMUST00000021197
AA Change: D383G

PolyPhen 2 Score 0.001 (Sensitivity: 0.99; Specificity: 0.15)
SMART Domains Protein: ENSMUSP00000021197
Gene: ENSMUSG00000020840
AA Change: D383G

DomainStartEndE-ValueType
Pfam:Peptidase_C1_2 5 451 1.8e-210 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000140193
Predicted Effect noncoding transcript
Transcript: ENSMUST00000158288
Predicted Effect probably benign
Transcript: ENSMUST00000168124
SMART Domains Protein: ENSMUSP00000130370
Gene: ENSMUSG00000020840

DomainStartEndE-ValueType
Pfam:Peptidase_C1_2 5 70 4.1e-11 PFAM
Coding Region Coverage
Validation Efficiency
MGI Phenotype FUNCTION: The encoded protein is a cytoplasmic cysteine peptidase involved in inactivation of bleomycin, a glycopeptide which is a component of combination chemotherapy regimens for cancer. This encoded enzyme is highly conserved, and it contains the signature active site residues of cysteine protease papain superfamily enzymes. It is postulated that this enzyme has protective effects against bleomycin-induced pulmonary fibrosis and bleomycin tumor resistance. [provided by RefSeq, Jan 2010]
PHENOTYPE: About one-third of homozygous null mutants die neonatally; survivors develop variably penetrant tail dermatitis and pulmonary fibrosis following bleomycin treatment. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 39 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Arhgap21 A G 2: 20,896,902 (GRCm39) C125R probably damaging Het
Brca1 T C 11: 101,416,061 (GRCm39) E691G probably damaging Het
Chrm3 G A 13: 9,928,500 (GRCm39) R179* probably null Het
Cnrip1 A G 11: 17,028,415 (GRCm39) T116A probably benign Het
Csmd2 T C 4: 128,389,934 (GRCm39) V2223A probably benign Het
Dalrd3 T A 9: 108,449,483 (GRCm39) V143D possibly damaging Het
Ddx60 A T 8: 62,432,375 (GRCm39) I886L probably damaging Het
Dennd4a T C 9: 64,804,635 (GRCm39) F1325L possibly damaging Het
Dnmt3l A T 10: 77,890,856 (GRCm39) T253S probably benign Het
Fads2b A G 2: 85,314,513 (GRCm39) L480P probably damaging Het
Ftdc1 G A 16: 58,436,170 (GRCm39) S51L probably benign Het
Gde1 T A 7: 118,297,860 (GRCm39) T9S probably damaging Het
Ggcx T A 6: 72,395,455 (GRCm39) probably benign Het
Hspg2 C T 4: 137,284,485 (GRCm39) A3481V probably damaging Het
Igf1r T C 7: 67,850,997 (GRCm39) Y931H possibly damaging Het
Ighv12-3 A C 12: 114,330,421 (GRCm39) S25A probably damaging Het
Itga5 A C 15: 103,256,193 (GRCm39) C920G probably damaging Het
Kmt5b A G 19: 3,846,681 (GRCm39) D118G probably benign Het
Lrp1b T G 2: 41,136,029 (GRCm39) N1647T possibly damaging Het
Lrrc71 T C 3: 87,649,079 (GRCm39) E363G probably benign Het
Mapk1 A G 16: 16,833,770 (GRCm39) Y41C probably benign Het
Mib1 T C 18: 10,747,357 (GRCm39) V178A probably damaging Het
Or13c7d A G 4: 43,770,366 (GRCm39) I215T probably benign Het
Or5m10b A G 2: 85,699,802 (GRCm39) I289V probably benign Het
Or5p52 A T 7: 107,502,649 (GRCm39) T242S probably benign Het
Plb1 T C 5: 32,521,541 (GRCm39) V1464A unknown Het
Plekhg5 T C 4: 152,187,479 (GRCm39) S82P probably damaging Het
Plxna4 T C 6: 32,494,494 (GRCm39) T41A probably benign Het
Ppip5k1 A C 2: 121,147,130 (GRCm39) probably null Het
Pttg1ip2 A G 5: 5,516,623 (GRCm39) probably null Het
Rpl14 T C 9: 120,402,639 (GRCm39) probably benign Het
Slc44a2 T C 9: 21,259,247 (GRCm39) F554L probably benign Het
Slco1b2 T A 6: 141,631,271 (GRCm39) V635E probably benign Het
Sv2a T A 3: 96,094,447 (GRCm39) C261S probably damaging Het
Thbs2 T C 17: 14,903,623 (GRCm39) I353V probably benign Het
Tspan4 G A 7: 141,071,941 (GRCm39) V205M probably damaging Het
Vezf1 A T 11: 87,967,047 (GRCm39) R93* probably null Het
Wwox T A 8: 115,433,108 (GRCm39) V258D probably damaging Het
Zmynd12 G T 4: 119,301,952 (GRCm39) probably benign Het
Other mutations in Blmh
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00514:Blmh APN 11 76,857,839 (GRCm39) missense probably damaging 1.00
IGL00661:Blmh APN 11 76,856,758 (GRCm39) nonsense probably null
IGL03350:Blmh APN 11 76,862,774 (GRCm39) missense probably damaging 1.00
R0570:Blmh UTSW 11 76,856,651 (GRCm39) missense probably damaging 1.00
R1519:Blmh UTSW 11 76,857,607 (GRCm39) missense probably damaging 1.00
R6724:Blmh UTSW 11 76,862,733 (GRCm39) critical splice acceptor site probably null
R7054:Blmh UTSW 11 76,859,451 (GRCm39) missense probably damaging 1.00
R7163:Blmh UTSW 11 76,836,987 (GRCm39) missense unknown
R7215:Blmh UTSW 11 76,856,725 (GRCm39) nonsense probably null
R7661:Blmh UTSW 11 76,877,341 (GRCm39) missense probably damaging 1.00
R7807:Blmh UTSW 11 76,837,040 (GRCm39) missense probably benign 0.03
R7843:Blmh UTSW 11 76,837,139 (GRCm39) missense probably damaging 1.00
R7895:Blmh UTSW 11 76,836,721 (GRCm39) critical splice donor site probably null
R7974:Blmh UTSW 11 76,856,729 (GRCm39) missense possibly damaging 0.92
R8150:Blmh UTSW 11 76,859,455 (GRCm39) missense probably benign 0.32
R8937:Blmh UTSW 11 76,857,883 (GRCm39) missense probably benign
R9756:Blmh UTSW 11 76,859,509 (GRCm39) missense probably damaging 1.00
Posted On 2015-04-16